Grant: Engage Grants Program
University of New Brunswick
$24,968.00
Traditionally used medicinal plants as sources of natural products with anticancer activity
EF 2013-14
Résumé
There is an obvious and urgent need to develop new drugs with novel modes of action to combat cancer. Thefailure of combinatorial, genomic and rational approaches to provide lead chemical structures and the currentrenaissance of natural product chemistry as a major contributor to the drug discovery process emphasizes theimportance of screening biodiversity for new chemical entities with novel biological activities. Naturalproducts research remains a valid and successful approach to drug discovery, especially when supplementedwith the wealth of information available through the ethnobotanical and ethnopharmacological knowledge ofthe Canadian First Nations. This approach will continue to reveal unprecedented lead structures with desirablebioactivities and potencies that are desperately required to develop new cancer therapies. The reticence of ""bigpharma"" to commit resources to natural product drug discovery has provided a unique opportunity for smallerbiotchnology companies to play an essential role in the drug development process. Socricimed Biopharma Inc.is one such Canadian company that has been successful in developing the anticancer therapeutic candidatesoricidin. However, the main challenge for small biotech drug discovery and development companies is exactlythe same as that which daunted big pharma: identifying a source of biologically active compounds to feed thedrug development pipeline. This project will evaluate whether medicinal plants and their associated endophyticfungi represent a valid source of new chemical entities that can supplement Soricimed Biopharma's drugdiscovery pipeline and ultimately facilitate the anticancer drug development process.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
New Brunswick, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
447562-2013
Name nom
Gray, Christopher
Department département
Chemistry
Organization id
75
Institution établissement
University of New Brunswick
Province en
New Brunswick
Province fr
Nouveau-Brunswick
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
24968
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1551
Committee name en
Atlantic Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Atlantique
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3701
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Natural products
Research subject fr
Produits naturels
Partie
1
Nb partie
1
Application title
Traditionally used medicinal plants as sources of natural products with anticancer activity
Keyword
NSERC
Application summary
There is an obvious and urgent need to develop new drugs with novel modes of action to combat cancer. Thefailure of combinatorial, genomic and rational approaches to provide lead chemical structures and the currentrenaissance of natural product chemistry as a major contributor to the drug discovery process emphasizes theimportance of screening biodiversity for new chemical entities with novel biological activities. Naturalproducts research remains a valid and successful approach to drug discovery, especially when supplementedwith the wealth of information available through the ethnobotanical and ethnopharmacological knowledge ofthe Canadian First Nations. This approach will continue to reveal unprecedented lead structures with desirablebioactivities and potencies that are desperately required to develop new cancer therapies. The reticence of ""bigpharma"" to commit resources to natural product drug discovery has provided a unique opportunity for smallerbiotchnology companies to play an essential role in the drug development process. Socricimed Biopharma Inc.is one such Canadian company that has been successful in developing the anticancer therapeutic candidatesoricidin. However, the main challenge for small biotech drug discovery and development companies is exactlythe same as that which daunted big pharma: identifying a source of biologically active compounds to feed thedrug development pipeline. This project will evaluate whether medicinal plants and their associated endophyticfungi represent a valid source of new chemical entities that can supplement Soricimed Biopharma's drugdiscovery pipeline and ultimately facilitate the anticancer drug development process.